news Horizon Discovery Group in-licenses oncology programme from Servier 7 October 2015 | By Victoria White Horizon Discovery Group has in-licensed novel kinase inhibitors from Servier that exhibit great promise based on preclinical data for treatment of a range of cancer types...
news Horizon and Redx sign cancer research collaboration 3 September 2015 | By Victoria White Horizon and Redx have announced a new research collaboration to progress Redx’s pan-RAF inhibitor programme, for out-licensing in oncology indications...
news Horizon Discovery Group plc acquires Sage Labs Inc. for $48M (£29M) 13 October 2014 | By Horizon Discovery Group Horizon Discovery Group plc announced it has agreed to acquire Sage Labs Inc. (Sage) for up to $16M (£9.8M) in cash and up to $32M (£19.6M) through the issue of new ordinary shares...
news Horizon Discovery Group plc acquires Sage Labs Inc. for $48M (£29M) 29 September 2014 | By Horizon Discovery Group Horizon Discovery Group plc announced it has agreed to acquire Sage Labs Inc...
news Horizon Discovery Group plc signs Master Services Agreement for approximately $1.2 million 25 September 2014 | By Horizon Discovery Agreement covers development of molecular reference standards for companion diagnostics...
news Horizon Discovery Group plc interim results for the six months ended 30 June 2014 23 September 2014 | By Horizon Discovery Horizon Discovery Group plc announces its interim results for the six months ended 30 June 2014...